⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

NIVABUPA - Investment Analysis: Buy Signal or Bull Trap?

← Back to List

⭐ Rating: 2.3

Last Updated Time : 19 Sept 26, 01:40 am

Key Parameters

⭐ Investment Rating: 2.3

ROE3.46 %
ROCE3.15 %
PEG Ratio0.66
Dividend Yield0.00 %
Debt to equity0.07
PAT Qtr138 Cr.
PAT Prev Qtr159 Cr.
Qtr Profit Var92.9 %
Show all parameters (20 more)
Stock CodeNIVABUPA
Market Cap14,713 Cr.
Current Price79.6 ₹
High / Low91.4 ₹
Stock P/E84.4
Book Value20.5 ₹
Face Value10.0 ₹
DMA 5082.6 ₹
DMA 20081.1 ₹
Chg in FII Hold1.49 %
Chg in DII Hold-0.32 %
RSI38.5
MACD-1.17
Volume13,16,487
Avg Vol 1Wk13,65,208
Low price67.5 ₹
High price91.4 ₹
52w Index50.6 %
EPS0.94 ₹
Industry PE39.2

🏭 Industry

The insurance industry is generally characterized by slow, predictable growth driven by demographic trends and regulatory changes. Successful players maintain strong brand recognition, excellent claims management, and prudent capital allocation, all of which contribute to sustainable profitability over the long term. Given the current macroeconomic environment, preserving capital and maintaining a conservative balance sheet are paramount in this sector.

✅ Positive

Niva Bupa has received a positive credit rating from AM Best, indicating financial stability which is crucial for long-term insurance companies. Furthermore, the company demonstrated continued profitability with PAT of 138 Cr this quarter and consistent growth in premium income (Qtr Profit Var: 92.9%).

⚠️ Limitation

The extremely high Stock P/E ratio of 84.4 compared to the industry average of 39.2 suggests a significantly elevated valuation, potentially indicating overenthusiasm or anticipating unsustainable future growth which could lead to disappointment. The low ROCE and ROE figures (3.15% and 3.46% respectively) also raise concerns about returns relative to invested capital and may not provide sufficient margin for error during market downturns.

🧾 Long-Term Outlook

An ideal entry price zone would be between 75 ₹ and 80 ₹, capitalizing on the current valuation and reflecting a belief that the market has overreacted to recent earnings fluctuations. A holding period of 5-7 years is suggested, prioritizing consistent dividend collection and monitoring key metrics such as ROCE and ROE for signs of deterioration; if these fall below 4%, consider reducing exposure. Overall, this stock presents moderate risk due to its high valuation but has the potential for durable compounding given the insurer's credit rating and continued premium growth.

Choose Technical Analysis or Fundamental Analysis above to load it.

How NIVABUPA Rates Across All Strategies

★ 2.3
Entry Price: 78.0 ₹.
★ 2.3
I’d suggest a buy order at 78.5 ₹ with a stop-loss set at 74.0 ₹ for…
Investment
★ 2.3
You're viewing this analysis below.
★ 2.3
Given the exceptionally high valuation relative to its underlying fin…

NIFTY 50 · Investment

NEXT 50 · Investment

MIDCAP · Investment

SMALLCAP · Investment